Arginine–aminopeptidase in rat cardiac fibroblastic cells participates in angiotensin peptide turnover
Author:
- 1 March 2004
- journal article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 61 (4) , 724-735
Abstract
The aim of the present study was to elucidate the presence in rat cardiac fibroblastic cells of arginine-aminopeptidase and its involvement in the hydrolysis of angiotensin peptides. Peptidase activity was measured as hydrolysis of the synthetic substrates, aryl-p-nitroanilides. Immunoblottings were performed with antibodies to aminopeptidase B and Glyceraldehyde-3-phosphate dehydrogenase. Arginine-aminopeptidase found in cardiac fibroblasts (Fb) was arginine and lysine specific, sensitive to various aminopeptidase (AP) inhibitors and to the inhibitor of metalloproteases, 1.10-phenatroline. Experiments with arphamenine A, a specific inhibitor of aminopeptidase B, have shown the presence of two Arginine-aminopeptidase activities: arphamenine-sensitive: chloride-stimulated Arginine-aminopeptidase, and arphamenine-insensitive: chloride-insensitive Arginine-aminopeptidase. Transforming growth factor-beta1 stimulated both Arginine-aminopeptidase activities by approximately threefold. Immunoblot with an antibody specific to rat aminopeptidase B has revealed that arphamenine-sensitive: chloride stimulated aminopeptidase is aminopeptidase B. Arginine-p-nitroanilide hydrolysis was significantly inhibited by angiotensin peptides such as angiotensin (1-10), (1-8), (1-7), (1-4), (5-8), (4-8), (3-8), and (2-8) at the concentration of 50 micromol/l which was fourfold less than the Arginine-p-nitroanilide concentration. Our data show that chloride-insensitive Arginine-aminopeptidase could contribute to the hydrolysis of all studied angiotensin peptides in concert with other peptidases present in fibroblasts. Some of the peptides could probably not be hydrolyzed by Arginine-aminopeptidase. Instead, they could be first hydrolyzed by another peptidase in fibroblasts and the product of this hydrolysis could be a substrate for Arginine-aminopeptidase. The data obtained suggest that Arginine-aminopeptidase could perform processing of angiotensin peptides in the myocardium and participate in processes regulated by angiotensins such as fibrosis.Keywords
This publication has 41 references indexed in Scilit:
- Angiotensin and bradykinin metabolism by peptidases identified in cultured human skeletal muscle myocytes and fibroblastsPeptides, 1995
- Characterization and purification of T lymphocyte aminopeptidase B : A putative marker of T cell activationEuropean Journal of Immunology, 1993
- Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase MBiochemical Pharmacology, 1990
- Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase MBiochemical Pharmacology, 1989
- Substrate specificities of Cl−-activated arginine aminopeptidases from human and rat originArchives of Biochemistry and Biophysics, 1983
- Effect of Cl− on the function of the Cl−-activated arginine aminopeptidase purified from human erythrocytesArchives of Biochemistry and Biophysics, 1982
- Stimulatory effect of Bestatin, a new specific inhibitor of aminopeptidases, on the blastogenesis of guinea pig lymphocytesCellular Immunology, 1978
- Bestatin, a new specific inhibitor of aminopeptidases, enhances activation of small lymphocytes by concanavalin ABiochemical and Biophysical Research Communications, 1977
- Inhibition of aminopeptidase B and leucine aminopeptidase by bestatin and its stereoisomerArchives of Biochemistry and Biophysics, 1976
- The thiolesterase activity of leucine aminopeptidaseBiochimica et Biophysica Acta (BBA) - Enzymology, 1972